Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren
Zurich Open Repository and Archive (University of Zurich) · 28.11.2023
DOI: 10.5167/uzh-239014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 28.11.2023. Verfasst von Stricker und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The use of immune checkpoint inhibitors has fundamentally changed the treatment landscape of solid tumors in recent years. Even in advanced stages or in tumors with historically poor prognosis, such as triple-negative breast cancer, progression-free survival, as well as overall survival of affected individuals, have considerably improved. As a result, the side effects and consequences of therapy, their detection, and treatment are becoming an increasingly important part of patient follow-up.
Schlagwörter
Zitieren
APA
Stricker, Marie, H., Wicki, & Andreas (2023). Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-239014
Vancouver
Stricker, Marie H, Wicki, Andreas. Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren. Zurich Open Repository and Archive (University of Zurich). 2023. doi:10.5167/uzh-239014
BibTeX
@article{Stricker2023,
author = {Stricker and Marie, Helena and Wicki and Andreas},
title = {Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren},
journal = {Zurich Open Repository and Archive (University of Zurich)},
year = {2023},
doi = {10.5167/uzh-239014}
}
EUVIMED